DƯỢC LÍ Goodman & Gilman's The Pharmacological Basis of Therapeutics 12th, 2010

1622 for cytomegalovirus retinitis (published erratum appears in
N Engl J Med, 1992, 326:1172). N Engl J Med, 1996, 326:
213–220.
Tam RC, Lau JY, Hong Z. Mechanisms of action of ribavirin in
antiviral therapies. Antiviral Chem Chemother, 2002, 12:
261–272.
Tyring S, Engst R, Corriveau C. Famciclovir for ophthalmic zoster:
A randomised acyclovir controlled study. Br J Ophthalmol, 2001,
85:576–581.
Tyring SK, Beutner K, Tucker BA, et al. Antiviral therapy for
herpes zoster. Arch Fam Med, 2000, 9:863–869.
Vats A, Shapiro R, Singh R, et al. Quantitative viral load monitoring
and cidofovir therapy for the management of BK virus–
associated nephropathy in children and adults. Transplantation,
2003, 75:105–112.
Vitravene Study Group. Randomized dose-comparison studies
of intravitreous fomivirsen for treatment of cytomegalovirus
retinitis that has reactivated or is persistently active despite
other therapies in patients with aids. Am J Ophthalmol, 2002,
133:475–483.
SECTION VII
CHEMOTHERAPY OF MICROBIAL DISEASES
Wagstaff AJ, Faulds D, Goa KL. Acyclovir: A reappraisal of its
antiviral activity, pharmacokinetic properties and therapeutic
efficacy. Drugs, 1994, 47:153–205.
Whitley RJ, Hayden FG, Reisinger K, et al. Oral oseltamivir
treatment of influenza in children. Pediatr Infect Dis J, 2001,
20:127–133.
Wiley DJ, Douglas J, Beutner K, et al. External genital warts:
Diagnosis, treatment, and prevention. Clin Infect Dis, 2002,
35:S210–S224.
Winston DJ, Yeager AM, Chandrasekar PH, et al. Randomized
comparison of oral valacyclovir and intravenous ganciclovir
for prevention of cytomegalovirus disease after allogeneic
bone marrow transplantation. Clin Infect Dis, 2003,
36:749–758.
Young KC, Lindsay KL, Lee KJ. Identification of a ribavirin
resistant NS5B mutation of hepatitis C virus during ribavirin
monotherapy. Hepatology, 2003, 38:869–878.